Avaliação da terapêutica em pacientes de alto risco cardiovascular

• Autor(a) principal: Freire, Juliana Gomes
• Data de Publicação: 2019
• Outros Autores: Silva, Ricardo Pereira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
• Texto Completo: http://www.repositorio.ufc.br/handle/riufc/48294
• topic: Hipertensão; Infarto do Miocárdio; Diabetes Mellitus Tipo 2; Inibidores da Enzima Conversora de Angiotensina; Doenças Cardiovasculares; Hipolipemiantes

According to the Global Burden of Diseases study, for the year 2020, cardiovascular disease (CVD) will remain the leading cause of death and disability in both sexes in Brazil and worldwide. In our country, CVD are responsible for high frequency of hospitalizations, causing high medical and socioeconomic costs. Hence the need to improve the approach of these patients. Objective: to record the current clinical practice in the prescription of evidence-based pharmacological interventions. Methodology: an observational, transversal and descriptive study developed among HUWC patients from April 2014 to May 2015, including individuals at high cardiovascular risk. Results: the prevalent age range was between 50 and 70 years; 64.72% were women; 68.51% were brown and 24.72% white. Systemic arterial hypertension, dyslipidemia and diabetes mellitus were the main cardiovascular risk factors. About 64.62% of the patients had blood pressure under control. Conclusion: The use of optimized therapy is far from ideal; the largest portion of the study population reached the goal for BP control.